The United States Pharmacopeia today notified stakeholders that it is postponing the official effective dates of several new and revised standards pertaining to pharmaceutical handling until further notice while it reviews appeals to the standards. Those standards include general chapters <795> (Pharmaceutical Compounding – Nonsterile Preparations), <797> (Pharmaceutical Compounding – Sterile Preparations), and <825> (Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging). In addition, due to the pending appeals, USP new general chapter <800> (Hazardous Drugs Handling in Healthcare Settings) will remain official, but only informational and will not be applicable until the appeals process is complete. The AHA in November 2018 urged USP to delay the official dates of both USP <797> and <800> due to expedited implementation and compliance concerns.

Related News Articles

Headline
The Federal Emergency Management Agency resumed processing disaster relief funding for over 2,400 projects, including vital funding for hospitals, thanks to $…
Headline
Karie Gibson, a licensed clinical psychologist who leads one of the FBI’s five behavioral analysis units, shares a behavioral threat assessment approach to…
Headline
The president of NorthShore Highland Park Hospital discusses her team’s coordinated response to a mass shooting during the 2022 July Fourth parade in Highland…
Headline
The American Society for Health Care Risk Management named Tracy Melina of Nuvance Health 2023 Risk Management Professional of the Year. Melina, who…
Chairperson's File
September is National Preparedness Month. And today marks the 22nd anniversary of the 9/11 terrorist attacks in the U.S. To those who lost loved ones because…
Headline
The Department of Health and Human Services’ Office for Civil Rights Sept. 7 released a proposed rule intended to update and clarify requirements under…